| Literature DB >> 21163964 |
D Williams Parsons1, Meng Li, Xiaosong Zhang, Siân Jones, Rebecca J Leary, Jimmy Cheng-Ho Lin, Simina M Boca, Hannah Carter, Josue Samayoa, Chetan Bettegowda, Gary L Gallia, George I Jallo, Zev A Binder, Yuri Nikolsky, James Hartigan, Doug R Smith, Daniela S Gerhard, Daniel W Fults, Scott VandenBerg, Mitchel S Berger, Suely Kazue Nagahashi Marie, Sueli Mieko Oba Shinjo, Carlos Clara, Peter C Phillips, Jane E Minturn, Jaclyn A Biegel, Alexander R Judkins, Adam C Resnick, Phillip B Storm, Tom Curran, Yiping He, B Ahmed Rasheed, Henry S Friedman, Stephen T Keir, Roger McLendon, Paul A Northcott, Michael D Taylor, Peter C Burger, Gregory J Riggins, Rachel Karchin, Giovanni Parmigiani, Darell D Bigner, Hai Yan, Nick Papadopoulos, Bert Vogelstein, Kenneth W Kinzler, Victor E Velculescu.
Abstract
Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the genetic alterations in this tumor type, we searched for copy number alterations using high-density microarrays and sequenced all known protein-coding genes and microRNA genes using Sanger sequencing in a set of 22 MBs. We found that, on average, each tumor had 11 gene alterations, fewer by a factor of 5 to 10 than in the adult solid tumors that have been sequenced to date. In addition to alterations in the Hedgehog and Wnt pathways, our analysis led to the discovery of genes not previously known to be altered in MBs. Most notably, inactivating mutations of the histone-lysine N-methyltransferase genes MLL2 or MLL3 were identified in 16% of MB patients. These results demonstrate key differences between the genetic landscapes of adult and childhood cancers, highlight dysregulation of developmental pathways as an important mechanism underlying MBs, and identify a role for a specific type of histone methylation in human tumorigenesis.Entities:
Mesh：
Substances：
Year: 2010 PMID： 21163964 PMCID： PMC3110744 DOI： 10.1126/science.1198056
Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728